Prognostic factors of brain metastases from colorectal cancer

[1] Barnholtz-Sloan JS(2004)Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit Cancer surveillance system J Clin Oncol 22 2865-2872

[2] Sloan AE(2002)Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma Cancer 94 2698-2705

[3] Davis FG(1997)Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials Int J Radiat Oncol Biol Phys 37 745-751

[4] Vigneau FD(2000)Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases Int J Radiat Oncol Biol Phys 47 1001-1006

[5] Lai P(1984)Karnofsky performance status revisited: reliability, validity, and guidelines J Clin Oncol 2 187-193

[6] Sawaya RE(1989)Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916 Int J Radiat Oncol Biol Phys 16 669-673

[7] Schouten LJ(2012)Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy Int J Radiat Oncol Biol Phys 83 303-309

[8] Rutten J(2012)Validation of recursive partitioning analysis and diagnosis-specific graded prognostic assessment in patients treated initially with radiosurgery alone J Neurosurg 117 38-44

[9] Huveneers HA(2014)Prognostic models predicting survival of patients with brain metastases: integration of lactate dehydrogenase, albumin and extracranial organ involvement Clin Oncol (R Coll Radiol) 26 447-452

[10] Twijnstra A(2012)Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases J Clin Oncol 30 419-425

[1] Barnholtz-Sloan JS(2004)Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit Cancer surveillance system J Clin Oncol 22 2865-2872

[2] Sloan AE(2002)Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma Cancer 94 2698-2705

[3] Davis FG(1997)Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials Int J Radiat Oncol Biol Phys 37 745-751

[4] Vigneau FD(2000)Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases Int J Radiat Oncol Biol Phys 47 1001-1006

[5] Lai P(1984)Karnofsky performance status revisited: reliability, validity, and guidelines J Clin Oncol 2 187-193

[6] Sawaya RE(1989)Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916 Int J Radiat Oncol Biol Phys 16 669-673

[7] Schouten LJ(2012)Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy Int J Radiat Oncol Biol Phys 83 303-309

[8] Rutten J(2012)Validation of recursive partitioning analysis and diagnosis-specific graded prognostic assessment in patients treated initially with radiosurgery alone J Neurosurg 117 38-44

[9] Huveneers HA(2014)Prognostic models predicting survival of patients with brain metastases: integration of lactate dehydrogenase, albumin and extracranial organ involvement Clin Oncol (R Coll Radiol) 26 447-452

[10] Twijnstra A(2012)Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases J Clin Oncol 30 419-425